Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran
Primary Purpose
Vitamin D Deficiency, Diabetes Mellitus, Hypertension
Status
Completed
Phase
Phase 2
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
D-vitin, soft gelatin capsule (vitamin D3,50000 IU)
Placebo vitamin D3
Sponsored by
About this trial
This is an interventional treatment trial for Vitamin D Deficiency
Eligibility Criteria
Inclusion Criteria:
- Food insecure,
- Have fit criteria of metabolic syndrome; (WC>90 cm), obesity (BMI≥30 kg/m2), diabetes (FBS>100 mg/dl), high blood pressure (systolic >135 mmHg and diastolic >85 mmHg) and dyslipidaemia (LDL≥ 240 mg/dl, HDL<40 mg/dl, TC≥ 160 mg/dl; TG≥ 200 mg/dl),
- Vitamin D deficient; serum 25(OH) D level <30 ng/ml,
- No use of vitamin D supplementation before 60 days,
Exclusion Criteria:
- An inability or unwillingness to participate,
- Those who are already taking any type of vitamin D supplements,
- Individuals with a history of allergy,
- Those subjects with serious medical condition such as cancer, heart attack, stroke, and etc.,
- Illness that required corticosteroids or insulin,
- Drugs are known to influence vitamin D level; steroids, anti-acids, oestrogen,
- People with conditions that contradict vitamin D supplementation, for example, a history of hypercalcaemia, hepatic disease or renal stones, sarcoidosis, or malignancy,
Sites / Locations
- Maryam Zarei
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Intervention group
control group
Arm Description
Intervention group will receive 50,000 U vitamin D3 per week (equivalent to 1,250 μg) for 8 weeks
Control group will receive vitamin D as a placebo. placebo will be identical in appearance taste and odourless.
Outcomes
Primary Outcome Measures
Achieving 25 (OH) D upper than insufficient serum 25(OH) D level >30 ng/l.
According to the guidline, vitamin D deficiency will improve by taking vitamin D3 by 2 months.
Secondary Outcome Measures
Reduction anthropometry (BMI and WC),
Reduction of BMI, WC after 2 months intervention by vitamin D3
Improved Biomarker indicators (lipid profile)
Reduction of lipid profiles are important for this research after vitamin D3 intervention.
Improved Biomarker indicator FBS
Reduction of FBS by 2 months intervention via taking vitamin D
Improved blood pressure
Reduction of blood pressure after taking vitamin D for 2 months
Full Information
NCT ID
NCT03193944
First Posted
June 13, 2017
Last Updated
January 12, 2018
Sponsor
Alborz Medical University
Collaborators
Universiti Putra Malaysia
1. Study Identification
Unique Protocol Identification Number
NCT03193944
Brief Title
Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran
Official Title
Vitamin D Supplementation on Metabolic Syndrome Indicators Among Food Insecure, Vitamin D Deficient Older Adults in Karaj City, Alborz Province, Iran;
Study Type
Interventional
2. Study Status
Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
February 10, 2017 (Actual)
Primary Completion Date
May 10, 2017 (Actual)
Study Completion Date
July 10, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Alborz Medical University
Collaborators
Universiti Putra Malaysia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
General objective: To assess the effect of vitamin D supplementation on metabolic syndrome among food insecure and vitamin D deficient older adults in Karaj city, Alborz province in Iran. A two-arm randomised controlled trial (RCT) will be conducted by recruiting participants. Inclusion Criteria: Food insecure, metabolic syndrome; Vitamin D deficiency Exclusion Criteria: those who are already taking any type of vitamin D supplements, Individuals with a history of allergy, Those subjects with serious medical condition such as cancer, heart attack, stroke, and etc., Intervention group: The intervention will start from 10 of May 2017 to 11 of July 2017 for 2 months. The intervention group will receive 50,000 U vitamin D3 per week (equivalent to 1,250 μg) for 8 weeks plus pamphlets and brochures about nutrition and health at the beginning of the study. Control group: The respondents in control group will receive placebo plus brochures and pamphlets related to nutrition and health at the beginning of the study. The data collection process will identify the older adults for both groups; intervention and control. Consent will be obtained from those who are eligible. Anthropometric measurement (height, weight, body mass index, and waist circumference), blood pressure measurement, blood taking and three-day food record will be obtained during baseline from all study respondents in the intervention and control groups. Primary Output: Achieving 25 (OH) D upper than insufficient serum 25(OH) D level >30 ng/l. Secondary Output: Reduction anthropometry (body mass index (BMI) and waist circumference (WC), Improved Biomarkers indicators (lipid profile, fasting blood fast), improved blood pressure before and after intervention.
Detailed Description
This study aims to find relationships between food insecurity, vitamin D intakes and its impact on metabolic syndrome among older adults in a city in Alborz province in Iran, known as Karaj. This study has 2 parts; the first part is to determine the prevalence of food insecurity and vitamin D deficiency among older adults in Karaj city. The second part is an intervention study examining effects of vitamin D supplementation on metabolic syndrome (diabetes, obesity, hypertension, and dyslipidaemia) among older adults who have at least have risk factors of metabolic syndrome, food insecure and vitamin D deficient. The first part; the data collection process will be performed in a few stages. The first stage will be to initiate contacting with the health centres in Karaj city to identify the older adults. Appointments will be set after screening the study subjects who will be eligible. Consent will be obtained from those who were eligible. The preliminary information on demographic data, socioeconomics, food insecurity, dietary intake and sunlight exposure will be collected by using a set of questionnaires. The blood sample for measuring serum 25 (OH) D will be taken the same day as questionnaires were filled.
The second stage: The data collection process will be performed in few stages. The first stage will include of contact with health centres in Karaj city to identify the older adults for both groups; intervention and control. Consent will be obtained from those who will eligible. Anthropometric measurement (height, weight, body mass index, and waist circumference), blood pressure measurement, blood taking and three-day food record will be obtained during baseline from all study respondents in the intervention and control groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vitamin D Deficiency, Diabetes Mellitus, Hypertension, Lipid Metabolism Disorders, Obesity, Abdominal
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
A detailed explanation on research design, location and population, sampling technique, sample size, instrument, data collection, data analysis and potential limitations of the study are outlined in the following sections. This study aims to find relationships between food insecurity, vitamin D intakes and its impact on metabolic syndrome among older adults in a city in Alborz province in Iran, known as Karaj. This study has 2 parts; the first part is to determine the prevalence of food insecurity and vitamin D deficiency among older adults in Karaj city. The second part is an intervention study examining effects of vitamin D supplementation on metabolic syndrome (diabetes, obesity, hypertension, and dyslipidaemia) among older adults who has at least have risk factors of metabolic syndrome, food insecure and vitamin D deficient. The intervention group will receive vitamin D supplementation 50000 IU for 8 weeks.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention group
Arm Type
Active Comparator
Arm Description
Intervention group will receive 50,000 U vitamin D3 per week (equivalent to 1,250 μg) for 8 weeks
Arm Title
control group
Arm Type
Placebo Comparator
Arm Description
Control group will receive vitamin D as a placebo. placebo will be identical in appearance taste and odourless.
Intervention Type
Drug
Intervention Name(s)
D-vitin, soft gelatin capsule (vitamin D3,50000 IU)
Other Intervention Name(s)
cholecalciferol,
Intervention Description
Intervention group: The respondents in intervention group will receive 50000 vitamin D for 8 weeks. Plus, brochures and pamphlets related to nutrition and health.
Intervention Type
Drug
Intervention Name(s)
Placebo vitamin D3
Intervention Description
vitamin D as a placebo
Primary Outcome Measure Information:
Title
Achieving 25 (OH) D upper than insufficient serum 25(OH) D level >30 ng/l.
Description
According to the guidline, vitamin D deficiency will improve by taking vitamin D3 by 2 months.
Time Frame
by 2 months
Secondary Outcome Measure Information:
Title
Reduction anthropometry (BMI and WC),
Description
Reduction of BMI, WC after 2 months intervention by vitamin D3
Time Frame
by 2 months
Title
Improved Biomarker indicators (lipid profile)
Description
Reduction of lipid profiles are important for this research after vitamin D3 intervention.
Time Frame
by 2 months
Title
Improved Biomarker indicator FBS
Description
Reduction of FBS by 2 months intervention via taking vitamin D
Time Frame
by 2 months
Title
Improved blood pressure
Description
Reduction of blood pressure after taking vitamin D for 2 months
Time Frame
by 2 months
10. Eligibility
Sex
All
Gender Based
Yes
Gender Eligibility Description
Aged from 60 to 80 years old,
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Food insecure,
Have fit criteria of metabolic syndrome; (WC>90 cm), obesity (BMI≥30 kg/m2), diabetes (FBS>100 mg/dl), high blood pressure (systolic >135 mmHg and diastolic >85 mmHg) and dyslipidaemia (LDL≥ 240 mg/dl, HDL<40 mg/dl, TC≥ 160 mg/dl; TG≥ 200 mg/dl),
Vitamin D deficient; serum 25(OH) D level <30 ng/ml,
No use of vitamin D supplementation before 60 days,
Exclusion Criteria:
An inability or unwillingness to participate,
Those who are already taking any type of vitamin D supplements,
Individuals with a history of allergy,
Those subjects with serious medical condition such as cancer, heart attack, stroke, and etc.,
Illness that required corticosteroids or insulin,
Drugs are known to influence vitamin D level; steroids, anti-acids, oestrogen,
People with conditions that contradict vitamin D supplementation, for example, a history of hypercalcaemia, hepatic disease or renal stones, sarcoidosis, or malignancy,
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zarei
Organizational Affiliation
World Health Organization
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maryam Zarei
City
Karaj
State/Province
Alborz
Country
Iran, Islamic Republic of
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran
We'll reach out to this number within 24 hrs